Your Health, We Care
The most common adverse reactions (≥20% in either study) are thrombocytopenia, hemorrhage, bacterial infection, fatigue, dizziness, diarrhea, and nausea.
from FDA,2023.09
Major Cardiovascular Event Risk with MomelotinibRisk BackgroundMomelotinib belongs to the JAK inhibitor class. In studies of similar agents for rheumatoid arthritis, an increased i···【more】
Article source：Lucius LaosRelease date：2026-06-23Recommended：115
Momelotinib: Risk of Decreased Platelet and White Blood Cell CountsMomelotinib may cause or worsen decreases in platelet and white blood cell counts. Thrombocytopenia increases ble···【more】
Article source：Lucius LaosRelease date：2026-06-22Recommended：124
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
